Jpn. J. Infect. Dis., 65 (4), 334-336, 2012
To see a printable version of the article in the Adobe file format, click this [PDF] link.
Chieko Matsumoto1, Masashi Igarashi1, Rika A. Furuta2, Shigeharu Uchida1, Masahiro Satake1, and Kenji Tadokoro1
1Japanese Red Cross Society Blood Service Headquarters, Tokyo 135-8521; and 2Japanese Red Cross Kinki Block Blood Center, Osaka 567-0085, Japan 1Department of Public Health, 29-0498, Japan
(Received January 19, 2012. Accepted May 8, 2012)
*Corresponding author: Mailing address: Infectious Disease Research Dep. JRC Central Blood Inst. JRC, 2-1-67 Tatsumi, Koto-ku, Tokyo 135-8521, Japan. Tel: +81-3-5534-7522, Fax: +81-3-3521-4137, E-mail: このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。
SUMMARY: The xenotropic murine leukemia virus-related virus (XMRV) was first described as a novel human gammaretrovirus in prostate tumor tissues and was reported to be found in blood, suggesting the possibility of XMRV transmission via blood transfusion. The gag and env regions of the XMRV proviral DNA that were detected 1,030 blood samples collected from the greater Tokyo area were examined by real-time PCR analysis. However, XMRV infection was not found in the samples; this suggested that the risk of XMRV transmission via transfusion is very low in Japan.
